Phendimetrazine Tartrate NDC 10702-045

NDC codes

FDA NDC Directory

Product NDC (as listed)10702-045Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10702-0045Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
10702-045-01	10702004501	100 TABLET in 1 BOTTLE (10702-045-01)Marketed from Sep 15, 2010
10702-045-03	10702004503	30 TABLET in 1 BOTTLE (10702-045-03)Marketed from Sep 15, 2010
10702-045-10	10702004510	1000 TABLET in 1 BOTTLE (10702-045-10)Marketed from Sep 15, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Phendimetrazine Tartrate
Generic name (nonproprietary): phendimetrazine tartrate
Active ingredients: Phendimetrazine tartrate — 35 mg/1
Dosage form: Tablet
Route: Oral
Labeler: KVK-TECH, INC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091042
Marketing start: Sep 15, 2010
Listing expires: Dec 31, 2026
DEA schedule: CIII
Other FDA classes: Appetite Suppression (Physiologic effect)Increased Sympathetic Activity (Physiologic effect)
Identifiers: Product ID 10702-045_289ebb0b-370d-4ea1-e063-6394a90a1752SPL ID 289ebb0b-370d-4ea1-e063-6394a90a1752SPL set ID 07bf3488-09e7-436f-af3f-94c35a7be025RxCUI 979549UNII 6985IP0T80
Pharmacologic class: Sympathomimetic Amine Anorectic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410702004501 followed by a unit qualifier and the quantity

Package 10702-0045-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 6, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds ÷ 2.2 = kg; inches x 0.0254 = meters. Phendimetrazine tartrate is indicated for use as …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)